Whitehawk Therapeutics Inc (WHWK)

Currency in USD
3.9800
+0.1300(+3.38%)
Real-time Data·
Earnings results expected in 9 days
WHWK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.74004.0000
52 wk Range
1.57005.4950
Key Statistics
Prev. Close
3.85
Open
3.88
Day's Range
3.74-4
52 wk Range
1.57-5.495
Volume
195.71K
Average Volume (3m)
506.79K
1-Year Change
128.7356%
Book Value / Share
2.46
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WHWK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.5000
Upside
+88.44%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Whitehawk Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.5000
(+88.44% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Leerink
Buy9.00+125.56%-New CoverageJul 21, 2026
Leerink
Buy9.00+125.56%-New CoverageJul 13, 2026
B.Riley
Buy10.00+150.63%-New CoverageJun 25, 2026
Citizens
Buy8.00+100.50%-MaintainMay 11, 2026
Oppenheimer
Buy7.00+75.44%6.00MaintainMay 08, 2026

Earnings

Latest Release
May 07, 2026
EPS / Forecast
-0.32 / -0.03
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

WHWK Income Statement

Compare WHWK to Peers and Sector

Metrics to compare
WHWK
Peers
Sector
Relationship
P/E Ratio
−1.9x−2.8x−0.4x
PEG Ratio
0.01−0.050.00
Price/Book
1.8x2.6x2.6x
Price / LTM Sales
-27.0x3.0x
Upside (Analyst Target)
94.8%184.3%56.0%
Fair Value Upside
Unlock11.6%9.1%Unlock

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Employees
29

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.81M7.08%14.66M
Other Institutional Investors
53.14M92.92%204.58M
Public Companies & Retail Investors
0.000.00%0.00
Total
56.95M100.00%219.24M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Acuta Capital Partners, LLC8.71%4,685,91218,041
QVT Financial LP8.58%4,615,70917,770

People Also Watch

18.96
LEGN
+2.21%
7.850
ABSI
+0.90%
0.334
MREO
-2.54%
15.12
CLPT
+1.20%
3.241
NRXP
+2.89%

FAQ

What Is the Whitehawk Therapeutics (WHWK) Stock Price Today?

The Whitehawk Therapeutics stock price today is 3.9800 USD.

What Stock Exchange Does Whitehawk Therapeutics Trade On?

Whitehawk Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Whitehawk Therapeutics?

The stock symbol for Whitehawk Therapeutics is "WHWK."

What Is the Whitehawk Therapeutics Market Cap?

As of today, Whitehawk Therapeutics market cap is 214.6000M USD.

What Is Whitehawk Therapeutics's Earnings Per Share (TTM)?

The Whitehawk Therapeutics EPS (TTM) is -1.6717.

When Is the Next Whitehawk Therapeutics Earnings Date?

Whitehawk Therapeutics will release its next earnings report on Aug 12, 2026.

From a Technical Analysis Perspective, Is WHWK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Whitehawk Therapeutics Stock Split?

Whitehawk Therapeutics has split 1 times.

How Many Employees Does Whitehawk Therapeutics Have?

Whitehawk Therapeutics has 29 employees.

What is the current trading status of Whitehawk Therapeutics (WHWK)?

As of Aug 03, 2026, Whitehawk Therapeutics (WHWK) is trading at a price of 3.9800 USD, with a previous close of 3.8500 USD. The stock has fluctuated within a day range of 3.7400 USD to 4.0000 USD, while its 52-week range spans from 1.5700 USD to 5.4950 USD.

What Is Whitehawk Therapeutics (WHWK) Price Target According to Analysts?

The average 12-month price target for Whitehawk Therapeutics is 7.5000 USD, with a high estimate of 10 USD and a low estimate of 4 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +88.44% Upside potential.

What Is the WHWK After Hours Price?

WHWK's last after hours stock price is 3.5000 USD, the stock has decreased by -0.3500, or -9.0900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.